- Home
- AQMS vs ALBT Comparison
AQMS vs ALBT Comparison
Compare AQMS & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQMS
- ALBT
- Stock Information
- Founded
- AQMS 2014
- ALBT 2014
- Country
- AQMS United States
- ALBT United States
- Employees
- AQMS N/A
- ALBT N/A
- Industry
- AQMS Metal Fabrications
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AQMS Industrials
- ALBT Health Care
- Exchange
- AQMS Nasdaq
- ALBT Nasdaq
- Market Cap
- AQMS 5.5M
- ALBT 5.7M
- IPO Year
- AQMS 2015
- ALBT N/A
- Fundamental
- Price
- AQMS $0.53
- ALBT $2.71
- Analyst Decision
- AQMS Strong Buy
- ALBT
- Analyst Count
- AQMS 3
- ALBT 0
- Target Price
- AQMS $21.00
- ALBT N/A
- AVG Volume (30 Days)
- AQMS 6.3M
- ALBT 645.0K
- Earning Date
- AQMS 08-04-2025
- ALBT 08-18-2025
- Dividend Yield
- AQMS N/A
- ALBT N/A
- EPS Growth
- AQMS N/A
- ALBT N/A
- EPS
- AQMS N/A
- ALBT N/A
- Revenue
- AQMS N/A
- ALBT $807,235.00
- Revenue This Year
- AQMS N/A
- ALBT N/A
- Revenue Next Year
- AQMS $550.00
- ALBT N/A
- P/E Ratio
- AQMS N/A
- ALBT N/A
- Revenue Growth
- AQMS N/A
- ALBT N/A
- 52 Week Low
- AQMS $0.47
- ALBT $2.11
- 52 Week High
- AQMS $7.80
- ALBT $12.60
- Technical
- Relative Strength Index (RSI)
- AQMS 36.08
- ALBT 42.27
- Support Level
- AQMS $0.47
- ALBT $2.54
- Resistance Level
- AQMS $1.02
- ALBT $2.74
- Average True Range (ATR)
- AQMS 0.09
- ALBT 0.31
- MACD
- AQMS 0.01
- ALBT 0.00
- Stochastic Oscillator
- AQMS 6.58
- ALBT 13.97
About AQMS Aqua Metals Inc.
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.